Rapt Therapeutics, Inc. (RAPT)
58.02
+0.04
(+0.07%)
USD |
NASDAQ |
Mar 02, 16:00
Rapt Therapeutics Research and Development Expense (TTM) : 82.87M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Penumbra, Inc. | 83.18M |
| Amicus Therapeutics, Inc. | 135.84M |
| Disc Medicine, Inc. | 170.36M |
| Amylyx Pharmaceuticals, Inc. | 91.51M |
| Johnson & Johnson | 14.72B |